The Big Picture: PACS vendors vie for piece of software pie

Article

The Big Picture: PACS vendors vie for piece of software pieBy Kathy Kincade, EditorAs the healthcare industry finally catches up to the rest of the PC-based world, there is a growing need to create new programming and applications-development

The Big Picture:
PACS vendors vie for piece of software pie

By Kathy Kincade, Editor

As the healthcare industry finally catches up to the rest of the PC-based world, there is a growing need to create new programming and applications-development environments tailored to the needs of the medical community. Or is there?

With the increasing sophistication of PACS, certain components are becoming commodities. As a result, some vendors have begun searching for new revenue streams. And with the advent of enterprise-wide image distribution, software represents one potentially lucrative niche. This opportunity has drawn the attention of several PACS and modality vendors, which have created software platforms with the hope of attracting new business from both their customers and their competitors.

But is this just another example of trying to reinvent the wheel? A handful of software developers have been adequately serving this market for many years. In addition, the medical imaging community has been quite successful in its cooperative approach to standards development. Look at DICOM and HL7.

And then there is the open architecture of the PC itself, which overcomes the legacy-system problem and offers a number of non-healthcare-specific application-development tools created and refined by computer companies with immense resources and expertise at their disposal. Software is, after all, their business.

But not necessarily software that is specific to the needs of the medical imaging industry. That requires yet another level of expertise from developers who understand how the medical community works and what tools they need to help them do their jobs better.

© 2000 Miller Freeman, Inc., a United News & Media company

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.